The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models
Sara A. Flanigan(University of Colorado Anschutz Medical Campus), Stephen Leong(University of Colorado Cancer Center)
Cited by 44